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Abstract: Cannabis sativa L. is a dioecious plant belonging to the Cannabaceae family. The main
phytochemicals that are found in this plant are represented by cannabinoids, flavones, and terpenes.
Some biological activities of cannabinoids are known to be enhanced by the presence of terpenes
and flavonoids in the extracts, due to a synergistic action. In the light of all the above, the
present study was aimed at the multi-component analysis of the bioactive compounds present
in fibre-type C. sativa (hemp) inflorescences of different varieties by means of innovative HPLC and
GC methods. In particular, the profiling of non-psychoactive cannabinoids was carried out by means
of HPLC-UV/DAD, ESI-MS, and MS2. The content of prenylated flavones in hemp extracts, including
cannflavins A and B, was also evaluated by HPLC. The study on Cannabis volatile compounds
was performed by developing a new method based on headspace solid-phase microextraction
(HS-SPME) coupled with GC-MS and GC-FID. Cannabidiolic acid (CBDA) and cannabidiol (CBD)
were found to be the most abundant cannabinoids in the hemp samples analysed, while β-myrcene
and β-caryophyllene were the major terpenes. As regards flavonoids, cannflavin A was observed to
be the main compound in almost all the samples. The methods developed in this work are suitable
for the comprehensive chemical analysis of both hemp plant material and related pharmaceutical or
nutraceutical products in order to ensure their quality, efficacy, and safety.
Keywords: Cannabis sativa L.; hemp; cannabinoids; flavonoids; terpenes; HPLC; GC; MS.
1. Introduction
In recent years, Cannabis sativa L. has been the focus of the attention of the scientific community
all over the world, definitely becoming one of the most studied plants [1]. It is one of the two
representatives of the Cannabaceae family and nowadays it is widely distributed all over the world.
C. sativa has been cultivated for a long time for medicinal, food, and abuse purposes, together with its
use as a source of textile fibre [1,2].
The taxonomy of the plant has always represented a critical issue, due to the huge variability
within the same genus [1–3]. Recently, a monotypic classification has been preferred, in which
one species (C. sativa) is recognised and it is divided into different chemotypes on the basis of the
specific cannabinoid profile [3]. Nonetheless, in the pharmaceutical field, only two phenotypes
are considered, on the basis of the content in the psychoactive principle ∆9-tetrahydrocannabinol
(∆9-THC) [4]. In detail, the first one is drug-type Cannabis, which is rich in psychoactive ∆9-THC, and
is used for medicinal or recreational purposes [4]; the second one is fibre-type Cannabis (commonly
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known as hemp or industrial hemp), used for both textile or food purposes, which has content of
∆9-THC below the legal limit of 0.2–0.3% [2,5] and is rich in non-psychoactive cannabinoids. Currently,
69 hemp varieties have been approved for commercial use by the European Community [6].
The pharmaceutical interest in this plant has been mainly addressed to drug-type Cannabis, thanks
to its new therapeutic applications [7], while hemp is at the moment under-employed in this ambit.
However, the number of studies focused on the characterisation of fibre-type hemp varieties and on the
evaluation of the biological potential of non-psychoactive compounds has increased lately [2,3,8–16].
The chemistry of C. sativa is known to be very complex; indeed, several chemical classes have
been identified in the plant, encompassing terpenes, carbohydrates, fatty acids and their esters, amides,
amines, phytosteros, phenolic compounds, and cannabinoids [17]. From a chemical point of view,
the latter are meroterpenoids and they are specific of this plant [2,17]. Usually, the most abundant
cannabinoids present in fibre-type plants are cannabinoic acids, such as cannabidiolic acid (CBDA)
and cannabigerolic acid (CBGA), followed by their decarboxylated forms, namely cannabidiol (CBD)
and cannabigerol (CBG) (Figure 1) [9]. In plant tissues, cannabinoids are biosynthesized in the acid
form; environmental factors, such as heat and light, generally induce a spontaneous decarboxylation
process to form decarboxylated cannabinoids [2,4,9,16,18,19].
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Figure 1. Chemical structures of main non-psychoactive cannabinoids in hemp inflorescences. 
Among non-psychoactive cannabinoids, CBD represents the most promising one from the 
pharmaceutical point of view, due to its high anti-oxidant and anti-inflammatory activity, in addition 
to its anticonvulsant, anxiolytic, neuroprotective, and antibiotic properties [2,4,20–23]. CBDA has 
antimicrobial and anti-nausea properties [2,20,22], while CBG has anti-inflammatory, antimicrobial 
and analgesic activities [2,20,22,24].  
Concerning other phenolic compounds, several flavonoids have been identified in C. sativa, 
belonging mainly to flavones and flavonols [25]. In particular, cannflavin A and B represent hemp-
specific methylated isoprenoid flavones (Figure 2) [25]. Several biological effects have been ascribed 
to hemp flavonoids, including anti-inflammatory, anti-microbial, neuroprotective, and anti-
proliferative activities [17]. In particular, cannflavin A and B are known to possess an anti-
inflammatory action [17] and microsomal prostaglandin E2 synthase (mPGES-1) and 5-lipoxygenase 
(5-LO) have been identified as their molecular targets [26]. In addition to flavonoids, 
dihydrostilbenoids represent another class of polyphenolic substances isolated from hemp, of which 
canniprene is the main representative (Figure 2) [25]. As to canniprene, it has been demonstrated to 
exert an anti-inflammatory activity as well, by inhibiting the production of pro-inflammatory 
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Figure 2. Chemical structures of main flavonoids and related compounds in hemp inflorescences. 
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and sesquiterpenes [14,15,17,27–29], with β-myrcene and β-caryophyllene as the most representative 
compounds (Figure 3), respectively. As regards monoterpenes, β-myrcene is known to possess anti-
inflammatory, analgesic, and anxiolytic properties [17]. As for sesquiterpenes, β-caryophyllene was 
found to be an anti-inflammatory agent and to exert a gastric cytoprotector activity; it has been 
demonstrated also to be able to bind to the cannabinoid receptors type 2 (CB2) and, in this context, it 
can be considered as a phytocannabinoid [17]. 
 
Figure 3. Chemical structures of main terpenes in hemp inflorescences. 
Some biological activities of cannabinoids are known to be enhanced by the presence of other 
secondary metabolites in C. sativa extracts, such as in cases of sleeping disorders and anxiety [30]. 
This effect has been attributed to a strict interaction between cannabinoids and terpenes, resulting in 
a synergistic action [30]. As an example, terpenes are able to increase blood-brain barrier permeability 
and they can also interact with neurotransmitter receptors, thus contributing to cannabinoid-
mediated analgesic and psychotic effects [17]. Finally, also flavonoids may modulate the 
pharmacokinetics of some cannabinoids, by means of the inhibition of hepatic P450 enzymes [17]. 
With this in view, the development and application of advanced analytical methods for a 
comprehensive analysis of C. sativa extracts plays a pivotal role in order to have a reliable evaluation 
of their chemical composition both for a higher reproducibility of biological assays and also to 
guarantee the efficacy and safety in their pharmaceutical use.  
In the light of all the above, the present study was aimed at the first multi-component analysis 
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2. Results and Discussion
2.1. Extraction of Non-Psychoactive Cannabinoids and Flavonoids from Hemp Inflorescences
The development and application of a suitable extraction procedure covers a crucial role to
achieve a reliable characterization of a plant material. For what concerns cannabinoids, a simple
dynamic maceration (DM) at room temperature was applied by using ethanol (EtOH) as the extraction
solvent, which has been demonstrated to be the best solvent for the extraction of these bioactive
compounds [9]. EtOH is indeed a good solvent for the extraction of many phenolics from plant
material [31]. As a matter of fact, cannflavins A and B were detected in hemp ethanolic extracts as
well, but, conversely to cannabinoids, their content in the inflorescences was extremely low [8,10,25];
in addition, the concomitant presence of cannabinoids in the same extract made them difficult to be
quantified. For this reason, two different protocols were optimised and applied in this work for the
extraction of non-psychoactive cannabinoids and flavonoids from hemp.
Starting with the extraction conditions previously optimised for cannabinoids, the method was
modified as follows. First, the solvent was properly chosen in order to have a good yield of hemp
flavonoids from the plant material; to do this EtOH, acetone and ethyl acetate (EtOAc) were tested.
The extracts were also concentrated 25:1 before HPLC analysis, in order to increase the intensity of the
UV/DAD signal. Of the solvents tested, acetone resulted in being the best one and it was therefore
selected for use in the subsequent steps (Figure 4).
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Figure 4. HPLC-UV/DAD chromatograms of a hemp extract (sample C6) in acetone (blue line), EtOAc 
(red line) and EtOH (green line), recorded at 342 nm. For peak numbering, see Table 1. 
In order to reduce any possible interference from cannabinoids in the concentrated extract, a 
sample pre-treatment was considered necessary. Indeed, the amount of cannabinoids in hemp 
inflorescences is much higher than that of flavonoids; thus, the peaks related to these compounds in 
the extracts may interfere with the quantification of other constituents at 210 nm. Conversely to other 
phenolics, cannabinoids can dissolve also in non-polar solvents (i.g. n-hexane, chloroform, 
dichloromethane (DCM)) [9]; hence, a sample pre-treatment by means of DM repeated three times 
with a non-polar solvent, including n-hexane and its combination with DCM, ethyl ether and toluene, 
was tested to be suitable to remove cannabinoids. After this treatment, the residue was extracted 
three times with acetone by means of DM. As shown in Figure 5, n-hexane alone resulted in being 
the most suitable solvent for the sample pre-maceration in comparison with other non-polar solvents 
tested. Indeed, its combination with DCM or ethyl ether or toluene, led to a decrease in the final 
amount of flavonoids extracted from hemp.  
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in the extracts may interfere with the quantification of other constituents at 210 nm. Conversely to
other phenolics, cannabinoids can dissolve also in non-polar solvents (i.g. n-hexane, chloroform,
dichloromethane (DCM)) [9]; hence, a sample pre-treatment by means of DM repeated three times
with a non-polar solvent, including n-hexane and its combination with DCM, ethyl ether and toluene,
was tested to be suitable to r move cannabinoids. After this treatment, the residue was extracted three
times with acetone by means of DM. As show in Figure 5, n-hexane alone resulted in being the most
suitable solvent for the sample pre-maceration in comparison with other non-polar solvents tested.
Indeed, its combination with DCM or ethyl ether or toluene, led to a decrease in the final amount of
flavonoids extracted from hemp.
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Figure 5. (a) Effect of different pre-maceration procedures on flavonoid extraction from hemp 
(sample C6). Chromatograms obtained at 342 nm with pre-maceration with n-hexane (3x) (blue 
line), with n-hexane (2x) + dichloromethane (DCM) (1x) (red line), with n-hexane (2x) + ethyl ether 
(1x) (green line), with n-hexane (2x) + toluene (1x) (pink line). For peak numbering, see Table 1. (b) 
Effect of pre-maceration with n-hexane on cannabinoid removal from hemp (sample C6). 
Chromatograms obtained at 210 nm with pre-maceration with n-hexane (3x) (blue line) and 
without pre-maceration (red line). For peak numbering, see Table 1. 
 
Finally, in order to facilitate the removal of cannabinoids, a decarboxylation of the plant material, 
prior to the pre-maceration with n-hexane, was also taken into account in order to convert 
cannabinoic acids into their neutral counterparts, which are more soluble in this solvent. In particular, 
the plant material was heated at 120 °C for 1 h or at 80 °C for 2 h, respectively. After this 
decarboxylation step, the pre-maceration process with n-hexane and the extraction with acetone 
previously optimised were applied. As shown in Figure 6, the peak areas related to flavonoids 
decreased after the heating process and the removal of cannabinoids was not significantly increased; 
therefore, it was not further pursued. In the light of all the above, a two-step extraction, based on an 
initial pre-maceration of the plant material with n-hexane and on the subsequent extraction with 




Figure 6. (a) Effect of different thermal treatments on flavonoid extraction from hemp (sample C6). 
Chromatograms obtained at 342 nm without thermal treatment (blue line), with thermal treatment at 
80 °C for 2 h (red line), with thermal treatment at 120 °C for 1 h (green line). For peak numbering, see 
Table 1. (b) Effect of different thermal treatments on cannabinoid removal from hemp (sample C6). 
Chromatograms obtained at 210 nm without thermal treatment (blue line), with thermal treatment at 
80 °C for 2 h (red line), with thermal treatment at 120 °C for 1 h (green line). For peak numbering, see 
Table 1. 
The optimized extraction techniques, based on dynamic maceration at room temperature, did 
not cause the degradation of the compounds of interest or the formation of artefacts. 
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(a) Ef ect of differ nt pre-maceration procedures on flavonoid extraction fr m he p (sample
C6). Chromatogra s bt ined a 342 nm with pre-mace ation with n-hexane (3x) (blue line), with
n-hexane (2x) + dichloromethane (DCM) (1x) (red line), with -hexane (2x) + ethyl eth r (1x) (green
line), with n-hexane (2x) + toluene (1x) (pink line). For peak numbering, s e Tabl 1. ( ) Effect of
pre-maceration with n-hexane o cannabinoid removal from hemp (sample C6). Chromatograms
obtained at 210 nm with pre-maceration with n hexane (3x) (blue line) and without pre-maceration
(red line). For peak numb ring, see Tabl 1.
Finally, in order to facilitate the removal of cannabinoids, a decarboxylation of the plant material,
prior to the pre-maceration with n-hexane, was also taken into account in order to convert cannabinoic
acids into their neutral counterparts, which are more soluble in this solvent. In particular, the plant
material was heated at 120 ◦C for 1 h or at 80 ◦C for 2 h, respectively. After this decarboxylation
step, the pre-maceration process with n-hexane and the extraction with acetone previously optimised
were applied. As shown in Figure 6, the peak areas related to flavonoids decreased after the heating
process and the removal of cannabinoids was not significantly increased; therefore, it was not further
pursued. In the light of all the above, a two-step extraction, based on an initial pre-maceration of the
plant material with n-hexane and on the subsequent extraction with acetone, was selected as the best
protocol for hemp flavonoids.
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Figure 6. (a) Effect of different thermal treatments on flavonoid extraction from hemp (sample C6).
Chromatograms obtained at 342 nm without thermal treatment (blue line), with ther al treatment at
80 ◦C for 2 h (r d line), with thermal treatment at 120 ◦C f r 1 h (green line). For p ak numbering, see
Table 1. (b) Effect of different thermal treatm nts on c nnabinoid removal from hemp (s ple C6).
Chromatograms obtained at 210 n without thermal treatment (blue line), with ther al treatment
t 80 ◦C for 2 h (red l ), wit thermal trea ment at 120 ◦C for 1 h (green line). For pe k numb ring,
see Table 1.
The optimized extraction techniques, based on dynamic maceration at room temperature, did not
cause the degradation of the compounds of int rest or the formation of artefacts.
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2.2. HPLC Methods for the Analysis of Non-Psychoactive Cannabinoids and Flavonoids in Hemp Extracts
The aim of the present study was to provide a comprehensive analysis of the main bioactive
compounds in fibre-type C. sativa inflorescences. In this perspective, the development of HPLC
methods for the determination of non-psychoactive cannabinoids and hemp-specific phenolics was a
critical aspect of the research. RP-HPLC on C18 columns, with acidic methanol (MeOH) or acetonitrile
(ACN) used as the strong solvent eluent and acidic H2O as the weak one, is frequently used for
the analysis of cannabinoids in C. sativa extracts [3,9,13,16]. Indeed, the use of an acidic mobile
phase improves the separation performance, providing better peak shape and enhanced resolution,
along with the enhancement of their ionization in HPLC-ESI-MS and MS2 experiments [3,9,13].
For acidification, HCOOH is usually employed [3,9,13]. For our purpose, an Ascentis Express C18
(150 × 3.0 mm I.D., 2.7 µm, Supelco) as the chromatographic column and a gradient mobile phase
composed of H2O and ACN, both containing 0.1% of HCOOH were selected, on the basis of a previous
work [9].
The gradient elution with the same mobile phase was then properly modified for hemp flavonoids,
since peaks corresponding to cannflavins A and B were observed to elute with the solvent front.
Under the final conditions, a good resolution of peaks belonging to cannflavins A and B and other
hemp phenolics was achieved. Representative chromatograms obtained by using the two HPLC
methods are shown in Figure 7.
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2.3. Identification of Non-Psychoactive Cannabinoids and Flavonoids in Hemp Extracts
The identification of secondary metabolites in hemp extracts was carried out by combining
the information obtained from UV/DAD and MS detectors. For a complete characterisation,
the experimental data were compared with the literature [3,9,12,32] and with commercially available
reference standards.
The UV spectra were used to preliminarily assign the chromatographic peaks to a chemical class.
As a matter of fact, cannabinoic acids, such as CBDA and CBGA, can be easily distinguished from
their decarboxylated counterparts (CBD and CBG, respectively) by their UV/Vis spectra: CBDA and
CBGA are indeed characterised by three absorption maxima (λmax), one at 220–223 nm, a second one
at 266–270 nm and a third one around 305 nm; CBD and CBG show a first λmax at 210–215 nm and an
additional one at 270 nm [9,13]. Canniprene showed a UV/Vis spectrum comparable to that of neutral
cannabinoids, with a λm x at 204 nm and a minor one at 280 nm. Also cannflavins can be recognised on
the basis of their UV/Vis spectra, since they possess a representative chromophore: indeed, the spectra
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of cannflavins A and B showed a first λmax at 213–215 nm, a second one at around 273–274 nm and,
finally, one at 342 nm.
As regards MS and MS2, the experiments were carried out both in the positive and in the negative
ion mode. The MS and MS2 data are shown in Table 1. In particular, cannabinoic acids showed a
higher intensity of the signals in the negative ion-mode, as opposed to decarboxylated compounds
and canniprene, which ionised better in the positive ion mode. Conversely to cannabinoids, flavonoids
(cannflavin A and B) were only detectable when positively ionised.
As regards the MS data acquired in the positive ion mode, both CBDA and CBGA generated
sodium adduct ions [M + Na]+ [3], in addition to their pseudo-molecular ions [M + H]+. CBGA was
easily distinguished from CBDA, thanks to its different molecular weight. As to their MS2 spectra
carried out in the positive ion mode, both CBDA and CBGA showed base peaks related to the loss of
water (−18 u) at m/z 341 and 343, respectively. CBDA showed an additional product ion at m/z 285,
attributable to the loss of a C4H8 group [9,33], which was not observed in the MS2 spectrum of CBGA.
Both CBG and CBD showed product ions at m/z 233 and 207 in the MS2 experiments performed in the
positive ion mode, although their relative intensity was different. The product ion at m/z 259 in the
MS2 spectrum of CBD was due to the loss of a C4H8 group [9,33], probably from the side alkyl chain,
which was absent in the MS2 spectrum of CBG. As to canniprene, the MS spectrum carried out in the
positive ion mode showed the pseudo-molecular ion [M+H]+ at m/z 343 and a base peak at m/z 287,
due to the loss of a C4H8 group of the side prenyl group. In the MS spectra of cannflavins A and B
only the pseudo-molecular ion [M + H]+ was observed. The MS2 spectra of these compounds showed
only one intense fragment at m/z 313, generated after the loss of the side prenyl moiety.
As for the MS data obtained in the negative ion mode, both CBDA and CBGA generated
product ions corresponding to the loss of water (−18 u) and of CO2 (−44 u), together with their
pseudo-molecular ions [M − H]−. Concerning the MS2 spectra acquired in the negative ion-mode,
CBG generated a product ion at m/z 247, due to the loss of a C5H8 group; additional fragments were
observed at m/z 297, 271, and 204. The fragmentation of CBD in the negative ion-mode provided
almost exclusively one product ion at m/z 245, attributable to the loss of a C5H8 group, following a
retro Diels-Alder reaction, which is a common fragmentation pathway in the field of natural substances
when an ESI ion source is employed [9,34]. Canniprene generated its pseudo-molecular ion [M − H]−
at m/z 341 in the negative ion mode; its MS2 spectrum showed a major product ion at m/z 326,
attributable to the loss of a methyl group.
It should be specified that the two peaks that precede each cannflavin belong to different
flavonoids, which have not been identified. Even though the UV/Vis spectrum was observed to
resemble those of flavones, the molecular mass and the fragmentation pattern was found to be
different in the MS and MS2 experiments.
2.4. Validation Data of the HPLC Methods
Over the concentration range tested, the two HPLC-UV/DAD methods showed good linearity
(r2 > 0.999) for the reference standards chosen in this study (Table S1).
The limit of detection (LOD) values for chrysoeriol and canniprene were 0.4 and 0.1 µg/mL,
respectively, while for cannabinoids it ranged from 0.4 and 0.8 µg/mL. The limit of quantification
(LOQ) values obtained for cannflavins and canniprene were 1.3 and 0.3 µg/mL, respectively, while for
cannabinoids it was in the range 1.3–2.5 µg/mL (Table S1).
The low intra- and inter-day % relative standard deviation (%RSD) for retention times (≤2.4%)
and peak areas (≤3.2%) relative to the target compounds (Table S2) and their low intra- and inter-day
SD values for content (≤21.3 µg/g) (Table S3) indicate the high precision of both the chromatographic
system and the extraction procedure.
By taking into account all the information described above, it can be concluded that this method
is a reliable tool for the identification and quantification of flavonoids in fibre-type hemp, conforming
to the ICH guidelines.
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Table 1. Retention times, UV, MS, and MS2 data of the main non-psychoactive cannabinoids, flavonoids and related compounds in hemp extracts.
Peak Number Compound tR (min) UV λmax (nm) MS (m/z) a MS2 (m/z) a MS (m/z) b MS2 (m/z) b
1 CBDA 13.8 225,269,307 359, 341 * 219 (100), 261 (55), 285 (33), 232 (22) 357 339 (100), 313 (9)
2 CBGA 15.7 223,268,305 361, 343 * 219 (100), 261 (49), 233 (19) 359 341 (100), 359 (6)
3 CBG 17.1 207,231sh,273 317 207 (100), 233 (40), 280 (10) 315 271 (100), 204 (80), 247 (51), 297 (49)
4 CBD 17.9 209,232sh,276 315 259 (100), 233 (26), 221 (24), 207 (24) 313 245 (100), 210 (6)
5 CFL-B 14.5 215,273,342 370 313 (100) - -
6 Canniprene 16.9 204,280 343, 287 * 255 (100), 227 (98), 269 (11) 341 326 (100), 269 (84), 283 (43), 257 (12)
7 CFL-A 21.1 214,274,342 437 313 (100) - -
Experimental conditions as described in Sections 3.4 and 3.5. a Positive ion mode. b Negative ion mode. * Precursor ion.
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2.5. Quantitative Analysis of Non-Psychoactive Cannabinoids in Hemp by HPLC-UV/DAD
Quantitative data related to the content of non-psychoactive cannabinoids in hemp inflorescences
determined by means of the HPLC-UV/DAD method are shown in Table 2. Since all the samples
analysed are fibre-type hemp varieties, it is not surprising that the most abundant cannabinoids
were represented by CBDA and CBD [9]. In particular, samples C1, C3, and C6 showed the typical
cannabinoid profiles of the fresh plant material, with CBDA as the main compound, followed by
CBD. On the other hand, samples C2, C4, and C5 showed the opposite behaviour: as a matter of fact,
CBD represented the most abundant cannabinoid in these samples, followed by CBDA. This profile
may be attributed either to an aged plant material or to a non-optimal drying process applied to the
inflorescences or to unsuitable storage conditions that may have led to a partial conversion of the
parent cannabinoic acid into its neutral counterpart, via a decarboxylation process, which naturally
occurs with time under the action of heat and light [9].
The same trend was observed also for the other two major non-psychoactive cannabinoids, namely
CBGA and CBG, though their content was about 10 times lower in comparison to CBDA and CBD
and, in some cases, not quantifiable. Nevertheless, the amount of non-psychoactive cannabinoids
determined in the analysed samples is in agreement with what is described in the literature for the
content of cannabinoids in hemp female inflorescences [9].
Table 2. Amount (mg/g) of the main non-psychoactive cannabinoids in hemp inflorescences a.
Compound C1 C2 C3 C4 C5 C6
CBDA 22.6 ± 2.5 4.1 ± 1.7 36.4 ± 1.0 4.1 ± 0.1 3.7 ± 0.2 17.6 ± 0.4
CBGA 0.4 b 0.2 ± 0.1 0.6 b 0.2 b <LOQ 0.1 b
CBG <LOQ 0.3 ± 0.1 <LOQ 0.3 b <LOQ <LOQ
CBD 1.9 ± 0.2 5.9 ± 0.4 6.3 ± 0.3 5.9 ± 0.1 8.6 ± 0.5 6.4 ± 0.4
Experimental conditions as in Section 3.4. a Data are expressed as mean (n = 6) ± SD. b SD < 0.05.
2.6. Quantitative Analysis of Flavonoids and Related Compounds in Hemp by HPLC-UV/DAD
The content of the two flavonoids cannflavin A and B and the stilbenoid canniprene in the hemp
samples analysed in this work is shown in Table 3. Canniprene was not detected in any of the samples
analysed, even though its presence has been previously reported in the literature for fibre-type hemp
varieties, comprising C2 and C3 [8]. However, Allegrone et al. [8] observed that a huge variation in the
amount of canniprene in hemp inflorescences may occur; this can explain why this compound was not
detected in any of the samples analysed in this study [8].
As regards flavonoids, cannflavin A was observed to be the most abundant one in all the
samples, with the only exception of sample C3, which had a high content of both cannflavins A
and B. These quantification data are in good agreement with the existing literature [8,10,25].
Table 3. Amount (µg/g) of the main flavonoids and related compounds in hemp inflorescences a.
Compound C1 C2 C3 C4 C5 C6
CFL-A 163.4 ± 2.4 109.4 ± 5.7 318.9 ± 5.8 59.9 ± 3.4 89.5 ± 6.7 140.6 ± 12.5
CFL-B 100.9 ± 1.7 21.0 ± 2.6 412.2 ± 4.0 25.3 ± 0.2 61.4 ± 5.7 75.9 ± 6.6
Canniprene <LOD <LOD <LOD <LOD <LOD <LOD
Experimental conditions as in Section 3.4. a Data are expressed as mean (n = 6) ± SD. For sample C6, n = 18.
2.7. Extraction of Volatile Compounds from Hemp by HS-SPME
The terpene composition of hemp inflorescences has been found to enhance the biological activity
of hemp-based products [30]; in this perspective, the development of a fast and reliable procedure
for the extraction of the volatile compounds from the plant material is highly recommended for its
complete characterisation.
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HS-SPME is being increasingly selected as the technique of choice in the ambit of the extraction of
volatile compounds in the field of natural product research [14,15,27,28]. In this study, a new HS-SPME
procedure was optimised in order to achieve a reliable characterisation of the volatiles from hemp
inflorescences. To do this, sample C3 was used for the optimisation of the HS-SPME conditions, as the
essential oil from the same variety was also available.
Firstly, the performance of two different SPME fibres was assessed, including both a
polydimethylsiloxane (PDMS) and a divinylbenzene-carboxen-polydimethylsiloxane (DVB/CAR/
PDMS) fibre. The representative GC-FID chromatograms of the HS profile of hemp inflorescences
obtained by using the PDMS and the DVB/CAR/PDMS fibres are shown in Figure 8. In order
to compare the fibre performance, the same temperature, equilibrium time, and extraction time
were employed. The extraction efficiency of volatile compounds was found to be higher when the
DVB/CAR/PDMS fibre was used; this fibre was therefore selected for this work.
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Figure 8. Effect of fibre type on the HS-SPME-GC-FID profiles of hemp inflorescences (sample C3):
(a) PDMS fibre; (b) DVB/CAR/ fi re.
For the outcome of the overall extraction procedure, it is also important to properly set the
extraction temperature, together with the equilibrium time and the extraction time. On the basis of
previous data available in the literature [14,15,27,28], temperatures of 40, 60, and 80 ◦C, equilibrium
times of 20 and 30 min and extraction times of 10 and 20 min were evaluated in this study. As concerns
the effect of temperature, a lower temperature was found to be much better, since an increase in the
extraction temperature led to a loss in monoterpenes with respect to the sesquiterpenes. In general,
the chromatographic profile of hemp volatile compounds at 40 ◦C was characterised by higher peak
areas (Figure 9); therefore, it was finally sel cted as the optimal extraction temperature. Being the
sample submitted to a relatively low temperature, longer equilibri m and extraction times are usually
req ired for a satisfactory recover of v latile compounds; indeed, higher peak ar as were obtained
from hemp when an equilibrium time and an xtraction time f 30 and 2 min, respectively, were
appli d (Figure 10).
In Figure 11, a representative GC-FID chromatogram btained with the final HS-SPME conditions
is shown, reflecting the profile of the essential oil distilled from the same plant m terial.
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Figure 1 . (a) GC-FID chromatogram of hemp inflorescences obtained by ap lying the HS-SPME
procedure optimized (sample C3); (b) GC-FID chromatogram of the ssential oil of hemp sample C3.
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2.8. GC Methods for the Analysis of Volatile Compounds from Hemp
Hemp volatile compounds extracted by HS-SPME were analysed by GC-FID and GC-MS and they
were identified according to both their calculated linear retention index (LRI) and MS spectra, which
were compared with available data in the literature and MS spectral libraries, respectively. As shown
in Figure 12 and Table 4, the GC analysis allowed us to identify 44 compounds in hemp inflorescences.
In general, all the hemp samples analysed in this study displayed the same qualitative and
semi-quantitative profile: monoterpenes were the most represented class of compounds among
volatiles, ranging between 47% and 89% of the total peak area. Sample C5 was the only exception to
this trend, as the total area of sesquiterpenes (52% of the total area) was found to be higher than that
of monoterpenes.
β-Myrcene, α- and β-pinene, and limonene represented the most abundant compounds among
monoterpenes. It is worthy of notice that the head space of sample C2 had a remarkably high relative
content of α-pinene, while samples C4 and C6 displayed a notably high relative amount of limonene.
As to the sesquiterpenes, β-caryophyllene was the most abundant compound in all the samples
analysed, followed by α-humulene. Curiously, sample C5 was the one with the higher relative content
of caryophyllene oxide, followed by sample C2. It should be pointed out that samples C2 and C5 were
the same in that had a cannabinoid profile opposite to that of fresh plant material, further suggesting
their aging or non-optimal storage conditions.
Nevertheless, the GC data of the hemp inflorescences analysed in this work are in accordance
with the available one previously described in the literature relating to hemp essential oil or volatile
fraction [14,15,27–29].
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semi-quantitative profile: onoter nes were the most represented class of compounds amo g 
volatiles, ranging between 47% and 89% of the total peak ar a. Sample C5 was the only exception to 
this trend, s the total ar a of sesquiterpenes (52% of the total area) was found to be higher than that 
of monoterpenes.  
β-Myrc , α- and β-pinene, and limonene represented the most abundant compounds among 
monoterpenes. It is worthy of notice that the head s ace of sample C2 h d a remarkably high relative 
content of α-pinene, while samples C4 and C6 displayed a notably hig  relative amount of limonene. 
As to the sesquiterpenes, β-caryophyllene was the most abundant compound in all the samples 
analysed, followed by α-humulene. Curiously, sample C5 was the one with the higher relative 
content of caryophyllene oxide, followed by sa le 2. It should be pointed out that samples C2 
and C5 were the same in that had a cannabinoid profile opposite to t at of fresh plant material, 
further suggesting their aging or non- ptimal storage conditions.  
Nevertheless, the GC data of the hemp inflorescences analysed in this work are in accordance 





Figure 12. Representative GC-FID chromatogram obtained by using the HS-SPME method optimised 
for volatile compounds from hemp inflorescences (sample C3). For peak numbering, see Table 4. 
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Table 4. Semi-quantitative data (% relative peak area values) for volatile compounds from hemp inflorescences a.
Peak Number Compound LRI Calc. LRI Lit. c
% Relative Peak Area
C1 C2 C3 C4 C5 C6
1 α-Thujene 932 911 3.7 ± 1.1 1.4 ± 1.0 0.2 b 0.2 b 0.5 ± 0.1 -
2 α-Pinene 939 932 20.1 ± 0.5 40.1 ± 2.3 26.7 b 9.6 ± 0.4 15.9 ± 2.1 10.3 b
3 Camphene 952 957 0.3 b - 0.5 b 0.3 b 0.3 b 0.2 b
4 β-Pinene 980 978 5.7 b 9.3 ± 0.1 6.9 ± 0.1 2.9 ± 0.2 4.2 ± 0.3 3.7 b
5 β-Myrcene 1000 992 28.7 ± 0.1 12.9 ± 0.1 36.9 ± 0.2 32.1 ± 3.3 6.9 ± 0.5 34.1 ± 1.1
6 α-Phellandrene 1009 1007 0.1 b - 0.4 b 0.5 b - 0.3 b
7 ∆3-Carene 1014 1010 1.3 b 1.4 b 0.5 b 0.6 b - 0.3 b
8 α-Terpinene 1020 1018 - - 0.3 b 0.4 b - 0.3 ± 0.1
9 o-Cymene 1022 1021 0.1 b - 0.1 b 0.1 b 1.3 ± 0.1 -
10 p-Cymene 1028 1026 0.2 b - 0.1 b 0.5 ± 0.1 2.5 ± 0.1 0.8 ± 0.1
11 Limonene 1032 1035 2.4 b 2.3 ± 0.1 1.6 b 11.3 ± 0.5 3.5 ± 0.2 11.5 ± 0.3
12 cis-Ocimene 1042 1040 0.5 b 0.7 b 0.2 b 0.6 ± 0.1 0.4 ± 0.1 -
13 trans-Ocimene 1053 1097 7.1 ± 0.3 0.6 b 6.1 ± 0.2 5.2 ± 0.1 0.4 ± 0.1 0.5 b
14 γ-Terpinene 1062 1062 0.2 b - 0.3 b 0.4 b 0.3 b 0.5 b
15 α-Terpinolene 1093 1088 3.9 ± 0.1 - 7.9 ± 0.1 12.0 ± 0.8 1.4 ± 0.1 4.9 ± 0.1
16 Linalool 1104 1104 0.6 b - 0.1 b 0.3 b 0.8 ± 0.1 0.4 b
17 6-Camphenol 1106 1110 0.3 b - - 0.1 b 1.2 ± 0.1 -
18 neo-Alloocimene 1133 1143 0.4 b - 0.1 b 0.4 b 1.1 ± 0.2 -
19 Isopinocarveol 1145 1139 - 0.6 b - - 0.6 ± 0.1 -
20 Terpinen-4-ol 1181 1177 0.5 b - 0.2 b 0.3 b 3.3 ± 0.2 0.6 b
21 p-Cymen-8-ol 1183 1181 - - 0.1 b - 2.2 ± 0.2 -
22 α-Terpineol 1193 1195 0.1 b - - 0.1 b 0.7 ± 0.1 0.4 b
23 Eugenol 1371 1373 - - - 0.3 ± 0.1 - -
24 α-Copaene 1375 1376 - - - 0.8 ± 0.2 - 0.3 ± 0.1
25 Geranyl acetate 1379 1386 - - - 0.3 ± 0.1 - -
26 Ylangene 1389 1406 - - 0.1 b - - -
27 Z,Z-α-Farnesene 1415 1462 0.2 b 0.7 b - 0.1 b 1.2 b 0.4 b
28 α-Santalene 1423 1420 - - 0.1 b 0.1 b 0.3 b -
29 β-Caryopyllene 1430 1428 13.4 ± 0.1 18.1 ± 0.5 5.2 ± 0.1 8.1 ± 2.0 22.6 ± 1.0 21.8 ± 0.7
30 Z,E-α-Farnesene 1437 1486 - - - 0.1 b 2.2 b -
31 α-Guaiene 1444 1439 0.2 b 0.5 b 0.4 b 0.9 ± 0.3 - -
32 Aromadendrene 1446 1449 0.4 ± 0.1 - - 0.3 ± 0.1 - -
33 β-Farnesene 1460 1454 0.1 b - - 1.8 ± 0.5 0.3 b -
34 α-Humulene 1464 1455 2.8 b 4.6 ± 0.3 1.3 b 2.1 ± 0.5 8.7 ± 0.6 5.6 ± 0.2
35 Alloaromadendrene 1471 1467 0.3 b 0.6 b 0.1 b 0.3 ± 0.1 1.4 ± 0.2 0.2 b
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Table 4. Cont.
Peak Number Compound LRI Calc. LRI Lit. c
% Relative Peak Area
C1 C2 C3 C4 C5 C6
36 Germacrene D 1489 1480 - - - 0.1 b 0.5 b -
37 β-Selinene 1493 1485 0.3 b 0.6 b - 0.2 b 0.5 ± 0.1 0.1 b
38 Valencene 1496 1496 0.5 b - 0.1 b 0.1 b 1.4 ± 0.1 0.3 b
39 α-Selinene 1505 1494 0.4 b 0.4 b 0.1 b 0.1 b 1.2 ± 0.1 0.2 b
40 γ-Cadinene 1515 1514 0.3 b - - 0.6 ± 0.2 0.4 b -
41 δ-Cadinene 1532 1530 - - 0.1 b 0.4 ± 0.1 0.4 b -
42 α-Calacorene 1547 1542 - - - 0.6 ± 0.1 - 0.2 b
43 Celina-3,7(11)-diene 1554 1550 - - 0.6 b - 0.3 b -
44 Caryophyllene oxide 1591 1583 - 0.6 b 0.2 b 0.1 b 2.6 ± 0.4 -
Total 94.8 ± 0.9 95.4 ± 1.0 97.5 ± 1.3 95.3 ± 1.1 91.5 ± 1.6 97.9 ± 0.7
Experimental conditions as in Sections 3.7–3.9. a Data are expressed as mean (n = 3) ± SD. b SD < 0.05. c LRI data from NIST Chemistry WebBook, SRD 69, https://www.nist.gov.
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3. Materials and Methods
3.1. Chemicals and Solvents
Cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), cannabigerol (CBG), and cannabidiol
(CBD) standard solutions (1 mg/mL in methanol or acetonitrile) were purchased from Cerilliant
(Round Rock, TX, USA). Chrysoeriol was purchased from Sigma-Aldrich (Milan, Italy), while
canniprene was kindly provided by Dr. Federica Pollastro of the Department of Drug Sciences
of the University of Piemonte Orientale (Novara, Italy). Formic acid (HCOOH) and HPLC-grade
solvents, including EtOH, MeOH, ACN, acetone, EtOAc, n-hexane, DCM, ethyl ether and toluene,
were from VWR (Milan, Italy). H2O was purified by using a Milli-Q Plus185 system from Millipore
(Milford, MA, USA).
3.2. Hemp Plant Material
Six samples of fibre-type hemp female inflorescences (indicated in the text as C1–C6, respectively)
were analysed in this study. including Antal (C1), Carma (C2), Carmagnola (C3), China (C4), Codimono
(C5), and Fibrante (C6). These samples (about 100–500 g dry material each), belonging to different
breeding lines, were cultivated under the same agronomic conditions; they were kindly provided by
Dr. Gianpaolo Grassi of the research centre CREA-CIN (Rovigo, Italy) and they were certified for a
content of ∆9-THC below 0.2% (w/w). All the samples considered in this study were approved for
commercial use by the European Union [6].
The “Fibrante” sample (C6) was selected for the HPLC method development. The sample
“Carmagnola” (C3) was used for the optimisation of the HS-SPME procedure; an essential oil sample
of the same hemp variety, obtained by hydro-distillation, was also available for a comparison.
For each sample, hemp inflorescences were manually separated from twigs and seeds. After this
procedure, the samples were stored at +4.0 ◦C until required for chemical analysis. Hemp inflorescences
were ground in a mortar before the extraction.
3.3. Sample Preparation
3.3.1. Extraction of Non-Psychoactive Cannabinoids
Cannabinoids were extracted from hemp inflorescences by means of DM [9]. Briefly, a weighed
amount of sample (0.25 g) was extracted with 10 mL of EtOH as the extraction solvent at room
temperature for 15 min, under magnetic stirring. The solution was then paper filtered and the
residue was extracted with the same procedure twice more with 10 and 5 mL of solvent, respectively.
The filtrates of the three extractions were then combined and adjusted to 25 mL with the solvent in a
volumetric flask. Before the injection in the HPLC system, the extracts were filtered by using a 0.45 µm
PTFE filter into a HPLC vial.
The extraction procedure was repeated twice for each sample.
3.3.2. Extraction of Flavonoids and Related Compounds
A portion of 0.25 g of hemp inflorescences was treated with 10 mL of n-hexane at room temperature
for 15 min, under magnetic stirring, in order to remove non-psychoactive cannabinoids. The solution
was then filtered on a paper filter and the filtrate sent to waste. The same procedure was repeated twice
more, by adding 10 and 5 mL of solvent to the residue, respectively. The residue was then let to dry
and, subsequently, it was extracted with 10 mL of acetone. The solution was then filtered on a paper
filter into a volumetric flask and the residue was extracted with the same procedure twice more with 10
and 5 mL of solvent, respectively. The filtrates of the three extractions were then pooled, concentrated
under vacuum at 30 ◦C, and adjusted to a final volume of 1 mL with the extraction solvent. Before
the injection into the HPLC system, the extracts were filtered by using a 0.45 µm PTFE filter into a
HPLC vial.
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The extraction procedure was repeated twice for each sample.
3.3.3. Extraction of Volatile Compounds
HS-SPME was used for hemp volatiles. To do this, a manual holder and a 1 cm stable-flex
50/30 µm DVB/CAR/PDMS fibre were employed (Supelco, Bellefonte, PA, USA). Before GC analysis,
the fibre was conditioned in the injector, according to the instructions provided by the manufacturer.
A 400 mg amount of hemp inflorescences, previously ground, was placed in a 10 mL flat-bottom
headspace vial sealed with a magnetic crimp cap and PTFE/silicone septa (Supelco). Under the
optimized conditions, the sample was heated for 30 min during the equilibrium time in a thermostatic
bath at 40 ◦C. The SPME device was then inserted into the sealed vial by manually penetrating the
septum and the fibre was exposed to the headspace for 20 min during the extraction time. After
sampling, the SPME fibre was immediately inserted into the GC injector and thermally desorbed.
A desorption time of 5 min at 250 ◦C was used in the split-less mode. Before sampling, the fibre was
reconditioned for 5 min in the GC injector port at 250 ◦C.
The extraction procedure was repeated three times for each sample.
3.4. HPLC-UV/DAD Conditions
The HPLC-UV/DAD analyses were performed on an Agilent Technologies (Waldbronn, Germany)
modular model 1100 system, consisting of a vacuum degasser, a quaternary pump, an autosampler,
a thermostated column compartment and a diode array detector (UV/DAD). Chromatograms were
recorded by using an Agilent Chemstation for LC and LC-MS systems (Rev. B.01.03).
3.4.1. HPLC-UV/DAD Analysis of Non-Psychoactive Cannabinoids
The chromatographic conditions for the analysis of non-psychoactive cannabinoids were set on
the basis of a previous work [9]. HPLC analyses were carried out on an Ascentis Express C18 column
(150 mm × 3.0 mm I.D., 2.7 µm, Supelco, Bellefonte, PA, USA), with a mobile phase composed of 0.1%
HCOOH in both (A) H2O and (B) ACN. The gradient elution was modified as follows: 0–13 min 60%
B, 13–17 min from 60% to 80% B, 17–22 min from 80% to 90% B. The post-running time was 15 min.
The flow-rate was 0.4 mL/min. The column temperature was set at 30 ◦C. The sample injection volume
was 3 µL. The UV/DAD acquisitions were carried out in the range 190–600 nm, while chromatograms
were acquired at 210 nm (for decarboxylated cannabinoids) and at 220 nm (for cannabinoic acids) [9].
Three injections were performed for each sample.
3.4.2. HPLC-UV/DAD Analysis of Flavonoids and Related Compounds
Regarding the analysis of flavonoids and related compounds, the chromatographic column and
the mobile phase were the same as those used for the analysis of cannabinoids. Conversely, the gradient
elution was optimized as follows: 0–5 min 40% B, 5–20 min from 40 to 80% B; 20–35 min from 80%
to 90% B, which was held for 10 min. The post-running time was 10 min. The flow rate and the
sample injection volume were kept at 0.4 mL/min and 3 µL, respectively and column was kept at room
temperature. As regards detection, UV/DAD acquisitions were carried out in the range 190–600 nm,
while chromatograms were acquired at 210 nm (for canniprene) and at 342 nm (for cannflavins).
Three injections were performed for each sample.
3.5. HPLC-ESI-MS and MS2 Conditions
The HPLC-ESI-MS and MS2 analyses were performed on an Agilent Technologies modular 1200
system, equipped with a vacuum degasser, a binary pump, a thermostated autosampler, a thermostated
column compartment, and a 6310A ion trap mass analyser with an ESI ion source. The HPLC column
and the applied chromatographic conditions were the same as those reported for the HPLC-UV/DAD
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systems. In details, the chromatographic conditions described in Sections 3.4.1 and 3.4.2 were applied
for the HPLC-ESI-MS and MS2 experiments of cannabinoids and polyphenols, respectively.
The HPLC-ESI-MS system was operated both in the positive and in the negative ion mode. For the
positive ion mode, the experimental parameters were set as follows: the capillary voltage was 3.5 kV,
the nebulizer (N2) pressure was 32 psi, the drying gas temperature was 350 ◦C, the drying gas flow
was 10 L/min, and the skimmer voltage was 40 V. For the negative ion mode, the MS conditions were
the same as described above.
Data were acquired by Agilent 6300 Series Ion Trap LC/MS system software (version 6.2).
The mass spectrometer was operated in the full-scan mode in the m/z range 200–1200. MS2 spectra
were automatically performed with helium as the collision gas in the m/z range 50–1500, by using the
SmartFrag function, which automatically selects the precursor ion to be fragmented and it eliminates
the need for a time-consuming manual collision-induced dissociation (CID) voltage optimization [9].
3.6. HPLC-UV/DAD Method Validation
In this study, the validation of the HPLC-UV/DAD method for the determination of hemp
flavonoids and related compounds was carried out, since the chromatographic method for the
quantification of non-psychoactive cannabinoids was previously fully validated [9]. The validation
was performed in agreement with the international guidelines for analytical techniques for the quality
control of pharmaceuticals (ICH guidelines) [35].
As regards linearity, the stock standard solution of non-psychoactive cannabinoids (CBDA,
CBGA, CBG and CBD) was prepared as follows: an accurately measured volume of reference solution
(100–200 µL) was placed into a 1 mL volumetric flask; then, MeOH was added and the solution
was diluted to volume with the same solvent. As to flavonoids, the stock standard solution of each
compound (canniprene and chrysoeriol) was prepared by weighing an accurate amount of reference
compound (0.9 mg) into a 1 mL volumetric flask; then, the solution was adjusted to volume with
MeOH. The external standard calibration curve was generated by using six data points, covering
the concentration ranges: 2.5–200.0 µg/mL for CBDA, CBGA and CBD; 1.3–100.0 µg/mL for CBG;
0.3–23.4 µg/mL for canniprene, and 1.3–43.0 µg/mL for chrysoeriol. Three µL aliquots of each standard
solution were used for HPLC analysis. Injections were performed in triplicate for each concentration
level. The calibration curve was obtained by plotting the peak area of the compound at each level
versus the concentration of the sample. The quantification of non-psychoactive cannabinoids and
canniprene was performed by using their calibration curves. The amount of cannflavins A and B
in hemp samples was determined by using the calibration curve of chrysoeriol, having the same
chromophore, and the content was corrected by using the molecular weight ratio.
For reference compounds, the limit of detection (LOD) and the limit of quantification (LOQ) were
experimentally determined by HPLC analysis of serial dilutions of a standard solution to reach a
signal-to-noise (S/N) ratio of 3 and 10, respectively.
The precision of the extraction technique was validated by repeating the extraction procedure on
the inflorescence of the same hemp sample (C6) six times. An aliquot of each extract was then injected
and quantified. The precision of the chromatographic system was tested by performing intra- and
inter-day multiple injections of one extract from sample C6 and then checking the %RSD of retention
times and peak areas. Six injections were performed each day for three consecutive days.
3.7. GC-FID Analysis of Volatile Compounds
These analyses were performed on an Agilent Technologies 7820 gas chromatograph with a flame
ionization detector (FID). Compounds were separated on an Agilent Technologies HP-5 cross-linked
poly-5% diphenyl-95% dimethyl polysiloxane (30 m × 0.32 mm i.d., 0.25 µm film thickness) capillary
column. The column temperature was initially set at 45 ◦C, then increased to 100 ◦C at a rate of
2 ◦C/min up, then raised to 250 ◦C at a rate of 5 ◦C/min, which was held for 5 min. Helium was used
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as the carrier gas, at a flow rate of 1.0 mL/min. The injector and detector temperature was set at 250
and 300 ◦C, respectively.
3.8. GC-MS Analysis of Volatile Compounds
These analyses were carried out on a 7890A gas chromatograph coupled with a 5975C network
mass spectrometer (Agilent Technologies, Germany). Compounds were separated on an Agilent
Technologies HP-5 MS cross-linked poly-5% diphenyl-95% dimethyl polysiloxane (30 m × 0.25 mm
i.d., 1.00 µm film thickness) capillary column. The temperature program was the same as described
above. Helium was used as the carrier gas, at a flow rate of 0.7 mL/min. The injector, transfer line
and ion-source temperature was 250, 280, and 230 ◦C, respectively. MS detection was performed with
electron ionization (EI) at 70 eV, operating in the full-scan acquisition mode in the m/z range 40–400.
3.9. Qualitative and Semi-Quantitative Analysis of Volatile Compounds
Hemp volatile compounds were identified by comparing the retention times of the
chromatographic peaks with those of authentic reference standards run under the same conditions
and by comparing with the literature the linear retention index (LRI) relative to a mixture of
n-alkanes (C8–C40) in n-hexane loaded onto the DVB-CAR-PDMS fibre and injected under the same
conditions. Peak enrichment by co-injection with authentic reference compounds was also carried out.
Comparison of the MS-fragmentation pattern of the target analytes with those of pure components
was performed. A mass-spectrum database search was performed by using the National Institute of
Standards and Technology (NIST, Gaithersburg, MD, USA) mass-spectral database (version 2.0d, 2005).
The percentage relative amount of individual components was expressed as percent peak area relative
to total peak area.
4. Conclusions
A comprehensive analysis of the bioactive compounds in hemp inflorescences was carried out
in this research work for the first time. The chemical classes considered in this study encompassed
non-psychoactive cannabinoids, flavonoids and related compounds, and volatile compounds.
In detail, the qualitative and quantitative profiling of non-psychoactive cannabinoids was
performed by applying an HPLC method with UV/DAD, ESI-MS and MS2 detection. A new HPLC
method with UV/DAD, ESI-MS and MS2 detection was developed and validated for the analysis
of hemp-specific flavonoids, combined with a selective and simple extraction procedure. Finally,
the characterisation of the hemp volatile fraction was achieved by optimising a new HS-SPME-GC
procedure with FID and MS detection.
All the analytical methods developed in the present work clearly demonstrated the provision of
a comprehensive and reliable analysis of the bioactive compounds present in hemp inflorescences,
which are known to be characterised by a very complex composition. Therefore, they can be applied
for a detailed chemical characterisation of the plant material in order to monitor its composition and
guarantee a better reproducibility of biological assays, since several compounds may act synergistically,
and also in quality control to ensure the efficacy and safety of hemp-based products to be used in the
pharmaceutical and nutraceutical fields.
Supplementary Materials: The Supplementary Materials are available online. Table S1: linearity and sensitivity
data for compounds used as hemp standards, Table S2: intra- and inter-day precision data for retention time (tR)
and peak area of the main flavonoids in hemp extracts (sample C6), Table S3: intra- and inter-day precision data
for the extraction of the main flavonoids from hemp (sample C6).
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